The Experts below are selected from a list of 18 Experts worldwide ranked by ideXlab platform

Dryden S - One of the best experts on this subject based on the ideXlab platform.

Jürgen Stausberg - One of the best experts on this subject based on the ideXlab platform.

  • The best period for mortality rates associated with Hospital stay: Hospital mortality performs well for nonsurgical diagnostic groups
    Quality management in health care, 2020
    Co-Authors: Jürgen Stausberg
    Abstract:

    BACKGROUND: Mortality is widely used to assess quality of Hospital Care. Inpatient mortality is easily available in administrative data. The use of periods other than length of stay is questionable. We compared different overlapping and disjunctive periods for the calculation of mortality associated with Hospital Care. SUBJECTS AND METHODS: Information from public quality reports covering insured from local sickness funds were retrospectively recorded. Nineteen thousand eight hundred thirteen patients from 69 Hospitals were included for 5 tracers. The relationship between different periods, or time spans from admission to death or discharge, was assessed calculating the nonparametric correlation coefficient for mortality rates and standardized mortality ratios. The periods were Hospital stay, 30, 90, and 365 days after admission, 31 to 90 days, and 91 to 365 days. The variation within each period was assessed with the coefficient of variation. RESULTS: There is a strong relationship between overlapping periods for nonsurgical tracers with r > 0.559 (P < .001). The surgical tracers present a reverse relationship between 30-day and 91-day to 365-day mortality with r = -0.724 (P = .012) for colorectal carcinoma with operation and r = -0.490 (P = .028) for total hip replacement in case of femur fracture. Nonsurgical tracers show a decreasing variation of mortality rates with extending periods, whereas colorectal carcinoma shows a stable and small variation. CONCLUSIONS: For nonsurgical tracers, Hospital stay is the best period to assess mortality associated with Hospital stay. The courses (sequences of 4 mortality rates for one tracer in a Hospital) for surgical tracers, in particular colorectal carcinoma, appear as a harvesting effect with an association of high in-Hospital mortality with low mortality in the medium term.

Reiner Leidl - One of the best experts on this subject based on the ideXlab platform.

  • Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison
    Tobacco Control, 2006
    Co-Authors: Simone Neubauer, Robert Welte, Alexandra Beiche, Hans‐helmut-h. Koenig, Katharina Buesch, Reiner Leidl
    Abstract:

    Objective: To assess the negative health consequences and associated costs of cigarette smoking in Germany in 2003 and to compare them with the respective results from 1993. Methods: The number of deaths, years of potential life lost (YPLL), direct medical and indirect costs caused by active cigarette smoking in Germany in 2003 is estimated from a societal perspective. The method is similar to that applied by Welte et al, who estimated the cost of smoking in Germany in 1993. Therefore, a direct comparison of the results was possible. Methodological and data differences between these two publications and their effect on the results are analysed. Results: In 2003, 114 647 deaths and 1.6 million YPLL were attributable to smoking. Total costs were €21.0 billion, with €7.5 billion for acute Hospital Care, Inpatient rehabilitation Care, ambulatory Care and prescribed drugs; €4.7 billion for the indirect costs of mortality; and €8.8 billion for costs due to work loss days and early retirement. From 1993 to 2003, the proportionate mortality attributable to smoking remained relatively stable, rising from 13.0% to 13.4%. The smoking-attributable deaths in men is lowered by 13.7% whereas that in women increased by 45.3%. Total real direct costs rose by 35.8%, and total real indirect costs declined by 7.1%, rendering an increase of 4.7% to real total costs. Accountable factors are changes in cigarette smoking prevalence and in disease-specific mortality and morbidity, as well as a rise in general healthCare expenditure. Conclusions: Despite the growing knowledge about the hazards of smoking, the smoking-attributable costs increased in Germany. Further, female mortality attributable to smoking is much higher than it was in 1993.

Tahmeed Ahmed - One of the best experts on this subject based on the ideXlab platform.

  • Day clinic vs. Hospital Care of pneumonia and severe malnutrition in children under five: a randomised trial.
    Tropical Medicine & International Health, 2019
    Co-Authors: Hasan Ashraf, Nur H. Alam, Marufa Sultana, Selina A. Jahan, Nurshad Begum, Sharmin Farzana, Mohammod Jobayer Chisti, Mohiuddin Kamal, Abu Shamsuzzaman, Tahmeed Ahmed
    Abstract:

    OBJECTIVES: To evaluate the clinical outcomes and costs of managing pneumonia and severe malnutrition in a day clinic (DC) management model (outpatient) vs. Hospital Care (Inpatient). METHODS: Randomised clinical trial where children aged 2 months to 5 years with pneumonia and severe malnutrition were randomly allocated to DC or Inpatient Hospital Care. We used block randomisation of variable length from 8 to 20 and produced computer-generated random numbers that were assigned to one of the two interventions. Successful management was defined as resolution of clinical signs of pneumonia and being discharged from the model of Care (DC or Hospital) without need for referral to a Hospital (DC), or referral to another Hospital. All the children in both DC and Hospital received intramuscular ceftriaxone, daily nutrition support and micronutrients. RESULTS: Four hundred and seventy children were randomly assigned to either DC or Hospital Care. Successful management was achieved for 184 of 235 (78.3%) by DC alone, vs. 201 of 235 (85.5%) by Hospital Inpatient Care [RR (95% CI) = 0.79 (0.65-0.97), P = 0.02]. During 6 months of follow-up, 30/235 (12.8%) in the DC group and 36/235 (15.3%) required readmission to Hospital in the Hospital Care group [RR (95% CI) = 0.89 (0.67-1.18), P = 0.21]. The average overall healthCare and societal cost was 34% lower in DC (US$ 188 ± 11.7) than in Hospital (US$ 285 ± 13.6) (P 

Daniel H. Teitelbaum - One of the best experts on this subject based on the ideXlab platform.

  • 758 Pediatric Short Bowel Syndrome: the Cost of Caring for These Complex Patients
    Gastroenterology, 2008
    Co-Authors: Ariel U. Spencer, Debra S. Kovacevich, Michelle Mckinney-barnett, Christopher J. Maksym, Daniel H. Teitelbaum
    Abstract:

    Background: The economic impact of Care for short bowel syndrome (SBS) patients is unknown. Our institution provides not only Inpatient Care for a large pediatric SBS population, but also operates a comprehensive home-Care program (including infusion, durable medical equipment and nursing), allowing us to assess total cost of Care (COC) incurred with SBS. Methods: This study examined actual COC (defined from the payers' viewpoint, i.e., charges) of pediatric SBS. All charges were adjusted for inflation to mid-decade (2005) U.S. dollars. Costs were stratified as “Hospital Care” (Inpatient stays, procedures, and outpatient clinic charges) or “Home-based Care” (parenteral nutrition, enteral supplements, home nursing charges, pump charges, pharmaceuticals, and rentals). Total COC for all patients for the first 5 years after onset of SBS were assessed for each year. To detect the significance of potential secular trends, linear regression was performed using the least squares method. P